BODIPY and 2,3-Dihydrophthalazine-1,4-Dione Conjugates As Heavy Atom-Free Chemiluminogenic Photosensitizers

ACS Appl Bio Mater. 2021 Jun 21;4(6):5090-5098. doi: 10.1021/acsabm.1c00328. Epub 2021 Jun 8.

Abstract

We disclose an interesting concept for developing heavy atom-free chemiluminogenic photosensitizers. To accomplish this, conjugates 2 and 3, which are composed of boron-dipyrromethene (BODIPY) and 2,3-dihydrophthalazine-1,4-dione units, are investigated. 2 and 3 are compared in terms of their photophysical properties, chemiluminescence responses, and singlet oxygen production. Strikingly, the results indicate that decoration of BODIPY with the 2,3-dihydrophthalazine-1,4-dione scaffold boosts the singlet oxygen generation. Furthermore, treatment of epidermoid laryngeal carcinoma Hep-2 (Hep-2) cells with conjugates 2 and 3 results in efficient cellular internalization which ensures live- cell imaging of Hep-2 cells. Finally, it is noteworthy that in vitro cytotoxicity assays reveal that both 2 and 3 induce cytotoxicity when illuminated with red light. Thus, 2 and 3 represent heavy atom-free chemiluminogenic photosensitizers.

Keywords: BODIPY; CRET; chemiluminescence; heavy-atom free photosensitizer; photodynamic therapy (PDT).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Boron / pharmacology
  • Boron Compounds
  • Luminol / analogs & derivatives
  • Photochemotherapy* / methods
  • Photosensitizing Agents* / pharmacology
  • Porphobilinogen / analogs & derivatives
  • Singlet Oxygen

Substances

  • 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene
  • Boron Compounds
  • Photosensitizing Agents
  • dipyrromethene
  • 2,3-dihydro-1,4-phthalazinedione
  • Singlet Oxygen
  • Luminol
  • Porphobilinogen
  • Boron